ABMD Financial Facts

Other (expense) income, net: -39K
Research and development: 8.69M
See Full Income Statement

Total liabilities and stockholders' equity: 205.41M
Treasury stock at cost - 50,954 shares: -16.55M
See Full Balance Sheet

Abiomed Inc. (ABMD) Earnings

  |   Expand Research on ABMD
Next EPS Date 5/1/15 *Est. EPS Growth Rate +172.7% *Last Qtr.
Average EPS % Beat Rate +208.1% Revenue Growth Rate +34.2% *Last Qtr.
Average % Move 1-Wk after EPS +15.4% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
1/28/15 Q315 $0.30$0.04 +$0.26$62M$53.2M N/A Details
10/30/14 Q215 $0.03$0.02 +$0.01$51.8M$48.8M N/A Details
7/31/14 Q115 -$0.04N/A N/A $48.8M$297.1M N/A Details
5/1/14 Q414 $0.09$0.08 +$0.01$50.4M$50.93M N/A Details
1/30/14 Q314 $0.11$0.05 +$0.06$46.2M$46M Details
11/6/13 Q214 $0.03$0.00 +$0.03$44.3M$43.75M Details
8/1/13 Q114 -$0.04$0.06 -$0.10$42.7M$42.93M Details
5/2/13 Q413 $0.09$0.07 +$0.02$43.7M$41.95M Details